GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » YoY EBITDA Growth

G&E Healthcare Co (XKRX:299480) YoY EBITDA Growth : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. G&E Healthcare Co's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

G&E Healthcare Co's EBITDA per Share for the six months ended in . 20 was ₩0.00.

G&E Healthcare Co YoY EBITDA Growth Historical Data

The historical data trend for G&E Healthcare Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co YoY EBITDA Growth Chart

G&E Healthcare Co Annual Data
Trend
YoY EBITDA Growth

G&E Healthcare Co Semi-Annual Data
YoY EBITDA Growth

G&E Healthcare Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

G&E Healthcare Co's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

YoY EBITDA Growth (A: . 20 )
=(EBITDA per Share (A: . 20 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

G&E Healthcare Co's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 ) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G&E Healthcare Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

G&E Healthcare Co (XKRX:299480) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:066830 XKRX:266470 XKRX:388610 XKRX:072520 XKRX:251280 XKRX:446440 XKRX:215380 XKRX:322970 XKRX:283100 XKRX:950220 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
Website
http://www.geherbs.com.tw
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines